ReShape Lifesciences Inc. financial data

Symbol
RSLS on Nasdaq
Location
1001 Calle Amanecer, San Clemente, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 61.1 % -71.1%
Quick Ratio 51.1 % -44%
Debt-to-equity -327 % +47.7%
Return On Assets -119 % +7.24%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.69M shares -90.8%
Common Stock, Shares, Outstanding 133K shares -99.4%
Entity Public Float 5.64M USD +11.1%
Common Stock, Value, Issued 29K USD +867%
Weighted Average Number of Shares Outstanding, Basic 1.17M shares +6609%
Weighted Average Number of Shares Outstanding, Diluted 1.17M shares +6609%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 6.45M USD -19.8%
Research and Development Expense 1.76M USD -18.7%
Selling and Marketing Expense 583K USD -13%
General and Administrative Expense 6.37M USD -14.3%
Operating Income (Loss) -8.43M USD +16%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -4.47M USD +50.1%
Income Tax Expense (Benefit) 25K USD -60.3%
Net Income (Loss) Attributable to Parent -4.5M USD +50.1%
Earnings Per Share, Basic 229 USD/shares +97.5%
Earnings Per Share, Diluted 229 USD/shares +97.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 383K USD -63.6%
Accounts Receivable, after Allowance for Credit Loss, Current 700K USD -56.3%
Inventory, Net 2.55M USD -21.4%
Other Assets, Current 89.3K USD +62.3%
Assets, Current 584K USD -90.4%
Deferred Income Tax Assets, Net 28K USD +3.7%
Property, Plant and Equipment, Net 54.4K USD +13.3%
Operating Lease, Right-of-Use Asset 45.4K USD -77.5%
Intangible Assets, Net (Excluding Goodwill) 314K USD
Other Assets, Noncurrent 29K USD 0%
Assets 1.63M USD +17.9%
Accounts Payable, Current 536K USD -48%
Employee-related Liabilities, Current 986K USD +55.1%
Accrued Liabilities, Current 333K USD -82.4%
Liabilities, Current 6.6M USD +106%
Operating Lease, Liability, Noncurrent 16.7K USD -83.8%
Liabilities 6.62M USD +97.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -53.2K USD +40.3%
Retained Earnings (Accumulated Deficit) -56M USD +91.2%
Stockholders' Equity Attributable to Parent -4.99M USD -25.7%
Liabilities and Equity 1.63M USD -74.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.12M USD -2.27%
Net Cash Provided by (Used in) Financing Activities 3.95M USD
Net Cash Provided by (Used in) Investing Activities -7K USD -100%
Common Stock, Shares Authorized 20M shares -93.3%
Common Stock, Shares, Issued 133K shares -99.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.82M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 383K USD +157%
Deferred Tax Assets, Valuation Allowance 79.9M USD +3.85%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 79.9M USD +3.8%
Operating Lease, Liability 47.1K USD -78.2%
Depreciation 4K USD -33.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -4.52M USD +49.9%
Lessee, Operating Lease, Liability, to be Paid 49.8K USD -78.4%
Property, Plant and Equipment, Gross 608K USD
Operating Lease, Liability, Current 30.4K USD -73.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 59K USD -48.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 34K USD -70.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +14.5%
Deferred Income Tax Expense (Benefit) -4K USD -500%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.75K USD -81.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 59K USD
Deferred Tax Assets, Operating Loss Carryforwards 71.9M USD +5.85%
Preferred Stock, Shares Issued 3.08K shares
Preferred Stock, Shares Authorized 16M shares 0%
Unrecognized Tax Benefits 1.05M USD 0%
Operating Lease, Payments 28K USD +3.7%
Additional Paid in Capital 51.1M USD -92%
Preferred Stock, Shares Outstanding 3.08K shares
Amortization of Intangible Assets 33K USD -98.2%
Deferred Tax Assets, Net of Valuation Allowance 57K USD -38%
Share-based Payment Arrangement, Expense 74K USD -84.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares